Trial site
Sydney Retina Clinic and Day Surgery
Sydney, NSW 2000, AustraliaNot linked to an institution yet
- 6running trials
- 3closed trials
The trials here
What the 9 trials at this site are about, from their registry records.
- Phase
- Phase 35 trials
- Phase 1/21 trial
- Phase 21 trial
- Phase 2/31 trial
- Status
- Active, not recruiting5 trials
- Completed3 trials
- Recruiting1 trial
- Lead sponsor
- Hoffmann-La Roche3 trials
- Janssen Research & Development, LLC2 trials
- 4D Molecular Therapeutics1 trial
- Annexon, Inc.1 trial
- Genentech, Inc.1 trial
- and 1 more
Running trials
Recruiting
Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration
NCT07064759· Phase 3· 4D Molecular Therapeutics· Source
Contact: 4DMT Patient Advocacy
Recruiting
A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
NCT06635148· Phase 2/3· Janssen Research & Development, LLC· Source
Active, not recruiting
A Study Investigating the Efficacy and Safety of Intravitreal (IVT) Injections of Vonaprument (Formerly ANX007) in Participants With Dry Age-Related Macular Degeneration (AMD) With Geographic Atrophy (GA)
NCT06510816· Phase 3· Annexon, Inc.· Source
Active, not recruiting
Phase 1/2 Study of VOY-101 in Patients With Advanced Non-Neovascular Age-Related Macular Degeneration
NCT06087458· Phase 1/2· Perceive Biotherapeutics, Inc.· Source
Active, not recruiting
An Observational Study of the Progression of Intermediate Age-Related Macular Degeneration
NCT05300724· Genentech, Inc.· Source
Active, not recruiting
A Study of the Efficacy, Safety, and Pharmacokinetics of a 36-Week Refill Regimen for the Port Delivery System With Ranibizumab in Patients With Neovascular Age-Related Macular Degeneration (Velodrome)
NCT04657289· Phase 3· Hoffmann-La Roche· Source
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
Report an error